Beyond oncology, altered SLFN12 methylation in autoimmune diseases such as multiple sclerosis and Hashimoto’s thyroiditis highlights its broader role in immune homeostasis, where methylation shifts may drive either immune suppression or hyperactivation. Here, SLFN12 is linked to multiple sclerosis.